新医学Issue(11)：729-731,3.DOI:10.3969/g.issn.0253-9802.2014.11.006
尤瑞克林治疗急性脑梗死的临床疗效和安全性研究
Clinical study of urinary kallidinogenase in the treatment of acute cerebral infarction
摘要
Abstract
Objective To investigate the clinical efficacy of urinary kallidinogenase in the treatment of acute cerebral infarction. Methods One hundred and two patients with acute cerebral infarction were ran-domly divided into two groups:the urinary kallidinogenase treatment group (51 cases)and the control group (51 cases). All patients in the two groups were given Xueshuantong powder injection through intravenous drip, but only the former group was administered with the diluted urinary kallidinogenase (0.1 5 PNAU). European Stroke Scale (ESS)and Barthel Index (BI)were evaluated before the treatment and on Day 1 0 and Day 90 af-ter the treatment. Results ESS and BI of urinary kallidinogenase treatment group were markedly higher than those of the control group on Day 1 0 and Day 90 respectively (P<0.05 or 0.01 ). Conclusion In the treat-ment of acute cerebral infarction,urinary kallidinogenase is helpful to improve the neurological function with fe-wer adverse reactions.关键词
急性脑梗死/尤瑞克林/疗效/安全性Key words
Acute cerebral infarction/Urinary kallidinogenase/Efficacy/Safety引用本文复制引用
祁风,余科,韦朝霞,刘祖佑..尤瑞克林治疗急性脑梗死的临床疗效和安全性研究[J].新医学,2014,(11):729-731,3.基金项目
广州市荔湾区科技局计划项目 （）
